Form 8-K - Current report:
SEC Accession No. 0001193125-25-241556
Filing Date
2025-10-16
Accepted
2025-10-16 17:18:36
Documents
14
Period of Report
2025-10-16
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d933718d8k.htm   iXBRL 8-K 30737
2 EX-5.1 d933718dex51.htm EX-5.1 29217
6 GRAPHIC g933718dsp5.jpg GRAPHIC 4993
  Complete submission text file 0001193125-25-241556.txt   182638

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA itrm-20251016.xsd EX-101.SCH 2512
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE itrm-20251016_lab.xml EX-101.LAB 16902
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE itrm-20251016_pre.xml EX-101.PRE 10314
17 EXTRACTED XBRL INSTANCE DOCUMENT d933718d8k_htm.xml XML 3485
Mailing Address 3 DUBLIN LANDINGS NORTH WALL QUAY DUBLIN 1 L2 D01 H104
Business Address 3 DUBLIN LANDINGS NORTH WALL QUAY DUBLIN 1 L2 D01 H104 (872) 225-6077
Iterum Therapeutics plc (Filer) CIK: 0001659323 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38503 | Film No.: 251398401
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)